CASC has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Cascadian Therapeutics Inc's marketable securities for the quarter that ended in Sep. 2016 was $55.09 Mil.
Cascadian Therapeutics Inc's quarterly marketable securities declined from Mar. 2016 ($32.63 Mil) to Jun. 2016 ($29.88 Mil) but then increased from Jun. 2016 ($29.88 Mil) to Sep. 2016 ($55.09 Mil).
Cascadian Therapeutics Inc's annual marketable securities declined from Dec. 2013 ($50.75 Mil) to Dec. 2014 ($47.22 Mil) and declined from Dec. 2014 ($47.22 Mil) to Dec. 2015 ($28.51 Mil).
Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.
Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.
Please note, GuruFocus' marketable securities also includes "Other Short Term Investment".
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
Cascadian Therapeutics Inc Annual Data
Cascadian Therapeutics Inc Quarterly Data